Pralatrexate Impurity 2 | CAS 52454-37-2 - Request Quote
Pralatrexate Impurity 2
| SZ CAT No: | SZ-P084013 |
| CAS No | 52454-37-2 |
| Mol.F. | C20H21N7O5 |
| Mol.Wt. | 439.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pralatrexate Impurity 2 is chemically (4-(2-(2,4-Diaminopteridin-6-yl)ethyl)benzoyl)-L-glutamic acid. Pralatrexate Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Pralatrexate Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pralatrexate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 52454-37-2
Purchase 52454-37-2
Order 52454-37-2
Enquire 52454-37-2
price of 52454-37-2
52454-37-2 Supplier
52454-37-2 Manufacturer
52454-37-2 Exporter
buy high quality Pralatrexate Impurity 2
Purchase Pralatrexate Impurity 2
Pralatrexate Impurity 2 suppliers
Pralatrexate Impurity 2 manufacturers
Pralatrexate Impurity 2 price
Order Pralatrexate Impurity 2
Enquire Pralatrexate Impurity 2
Pralatrexate Impurity 2 cost
Pralatrexate Impurity 2 Supplier
Pralatrexate Impurity 2 Distributor
Pralatrexate Impurity 2 for Method Validation
Pralatrexate Reference Standard
Pralatrexate Impurity 2 for ANDA Filing
Pralatrexate Impurity 2 for Forced Degradation Studies
Pralatrexate Impurity 2 Identification Standards
Pralatrexate Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.